WaveBreak Therapeutics
PrivateLast Round
VC Round
Jan 25, 2021
Total Funding Raised
$23M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
WaveBreak Therapeutics operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a VC Round in January 2021.
WaveBreak Therapeutics is a biotechnology company that develops a platform of therapeutics to target protein-misfolding diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WaveBreak Therapeutics Comparables
Compare WaveBreak Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Treventis Corporation | 87% | |
| Gismo Therapeutics | 84% | |
| MODAG | 81% |
For institutional investors. Book with your work email.
WaveBreak Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 25, 2021 | ||||
| Series A | Jan 22, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
WaveBreak Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lifeforce Capital | Series A, VC Round |
| Schooner Capital | VC Round |
| Industry Ventures | VC Round |
| The Baupost Group | Series A, VC Round |
| Malin PLC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 321% MoM, reaching 2K.
- Jun 18, 2026
Monthly visitors increased 160% MoM.
For institutional investors. Book with your work email.
WaveBreak Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about WaveBreak Therapeutics's valuation, stock price, and market status.
Is WaveBreak Therapeutics a public or private company?
WaveBreak Therapeutics is a private company.
What is the current stock price of WaveBreak Therapeutics?
WaveBreak Therapeutics is a private company, so its shares have no public market price. Caplight tracks WaveBreak Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is WaveBreak Therapeutics worth (valuation)?
Valuation information for WaveBreak Therapeutics is not publicly available.
Can I buy WaveBreak Therapeutics stock?
WaveBreak Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was WaveBreak Therapeutics's last funding round?
WaveBreak Therapeutics's most recent funding round was VC Round on January 25, 2021.
Who are the main investors in WaveBreak Therapeutics?
Key investors in WaveBreak Therapeutics include The Baupost Group.
Will WaveBreak Therapeutics IPO soon?
No public IPO plans have been announced for WaveBreak Therapeutics.
How can I track WaveBreak Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in WaveBreak Therapeutics's shares on secondary markets.